1. Home
  2. CRBP vs SHIM Comparison

CRBP vs SHIM Comparison

Compare CRBP & SHIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBP
  • SHIM
  • Stock Information
  • Founded
  • CRBP 2009
  • SHIM 1990
  • Country
  • CRBP United States
  • SHIM United States
  • Employees
  • CRBP N/A
  • SHIM N/A
  • Industry
  • CRBP Biotechnology: Pharmaceutical Preparations
  • SHIM
  • Sector
  • CRBP Health Care
  • SHIM
  • Exchange
  • CRBP Nasdaq
  • SHIM Nasdaq
  • Market Cap
  • CRBP 114.8M
  • SHIM 97.5M
  • IPO Year
  • CRBP N/A
  • SHIM 2023
  • Fundamental
  • Price
  • CRBP $16.22
  • SHIM $2.46
  • Analyst Decision
  • CRBP Strong Buy
  • SHIM
  • Analyst Count
  • CRBP 8
  • SHIM 0
  • Target Price
  • CRBP $50.57
  • SHIM N/A
  • AVG Volume (30 Days)
  • CRBP 221.8K
  • SHIM 22.9K
  • Earning Date
  • CRBP 11-06-2025
  • SHIM 11-11-2025
  • Dividend Yield
  • CRBP N/A
  • SHIM N/A
  • EPS Growth
  • CRBP N/A
  • SHIM N/A
  • EPS
  • CRBP N/A
  • SHIM N/A
  • Revenue
  • CRBP N/A
  • SHIM $520,100,000.00
  • Revenue This Year
  • CRBP N/A
  • SHIM $5.42
  • Revenue Next Year
  • CRBP $220.00
  • SHIM $6.67
  • P/E Ratio
  • CRBP N/A
  • SHIM N/A
  • Revenue Growth
  • CRBP N/A
  • SHIM N/A
  • 52 Week Low
  • CRBP $4.64
  • SHIM $1.30
  • 52 Week High
  • CRBP $20.77
  • SHIM $3.78
  • Technical
  • Relative Strength Index (RSI)
  • CRBP 76.29
  • SHIM 37.36
  • Support Level
  • CRBP $15.00
  • SHIM $2.67
  • Resistance Level
  • CRBP $16.97
  • SHIM $2.91
  • Average True Range (ATR)
  • CRBP 1.01
  • SHIM 0.18
  • MACD
  • CRBP 0.28
  • SHIM -0.05
  • Stochastic Oscillator
  • CRBP 88.62
  • SHIM 10.08

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About SHIM Shimmick Corporation

Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.

Share on Social Networks: